JDRF Applauds Usher and NFL Star Noah Gray for Shining a Spotlight on Type 1 Diabetes at Super Bowl LVIII
eTravel Wire/10272099

Trending...
NEW YORK, Feb. 12, 2024 ~ JDRF, the leading global organization for type 1 diabetes (T1D) research and advocacy, has recognized two individuals for their efforts in raising awareness for the disease during Super Bowl LVIII. Grammy award-winning artist Usher and NFL Super Bowl Champion Noah Gray of the Kansas City Chiefs have both been acknowledged for shining a spotlight on T1D.

Usher, whose teenage son was diagnosed with T1D at the age of six, used his platform as he prepared for his highly anticipated Super Bowl Halftime Show and the release of his upcoming album to bring attention to T1D and the importance of early detection. In various media interviews leading up to the event, Usher shared his personal journey as a parent of a child with T1D and stressed the need for greater knowledge and understanding about the disease.

According to JDRF CEO Aaron Kowalski, Usher's advocacy has played a crucial role in raising awareness about T1D and promoting early detection through screening. By educating people about the symptoms of T1D and encouraging them to get screened, there is a reduced risk of life-threatening complications and hospitalizations during diagnosis. Additionally, early detection allows families time to plan, prepare, and possibly benefit from therapies that can delay the onset of T1D.

More on eTravel Wire
Noah Gray, a standout tight end for the Kansas City Chiefs, was diagnosed with T1D during his freshman year at Duke University. Despite this challenge, Gray remained determined to pursue his dreams and learned how to manage his diabetes while excelling academically and athletically. His hard work paid off when he was selected by the Chiefs in the 2021 NFL draft. Gray played a significant role in helping his team win Super Bowl LVIII against the San Francisco 49ers yesterday, adding another championship title to his resume. He serves as an inspiration for individuals with T1D that with hard work and access to the right tools, they can compete in sports at every level.

T1D is an autoimmune disease that affects over 1.4 million Americans. It causes the pancreas to produce little or no insulin, and those with T1D must carefully monitor their blood glucose levels and administer insulin to survive. This condition can affect people of any age, and currently, there is no cure.

More on eTravel Wire
JDRF emphasizes the importance of T1D screening, which involves a blood test to check for specific autoantibodies that indicate the body's immune system is attacking the insulin-producing cells in the pancreas. Screening allows families to plan and prepare for a potential diagnosis and prevent severe complications like diabetic ketoacidosis (DKA) and hospitalization. It also opens up opportunities for individuals to receive therapies that can delay the onset of T1D or participate in studies for other innovative treatment options.

To learn more about T1D screening, JDRF's education and awareness program T1Detect provides information on where to get screened and what steps to take after receiving results. Visit JDRF.org/T1Detect for more information.
Show All News | Report Violation

0 Comments

Latest on eTravel Wire

Related Posts